Investors

Investors arrow
Print E-mail
Investor Relations

Peregrine Pharmaceuticals, Inc.

Corporate and Media Relations

Investors

14282 Franklin Avenue,
Tustin, CA 92780
Phone: 714-508-6000
Fax: 714-838-5817

Linda Donaldson
14282 Franklin Avenue
Tustin, CA 92780

Tel: 714-508-6067
Fax: 714-838-5817
pr@peregrineinc.com

GendeLLindheim BioCom Partners, LLC
Barbara Lindheim
48 Wall Street, Suite 1100
New York, NY 10005 

Tel: 212-918-4949
Tel: 800-987-8256


Featured Event  
Nov 16, 2009
Chemical and Biological Defense Science and Technology (CBD S&T) Conference


Recent Press Releases  
Nov 18, 2009
Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science & Technology Conference
Nov 10, 2009
New Study in Clinical Cancer Research Shows Therapeutic Promise of Peregrine's Bavituximab With Radiation in a Lethal Brain Cancer Model

View all releases »

Upcoming Events  
Dec 10, 2009 at 11:30 AM ET
Second Quarter Fiscal Year 2010 Financial Results Conference Call
Dec 10, 2009 at 11:30 AM ET
Second Quarter Fiscal Year 2010 Financial Results Conference Call

View all events & presentations »

Stock Information  
NASDAQ:PPHM
$2.95   - 0.07
Nov 20, 2009
4:00 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.
Shareholder Tools  
 
 
© 2003/2009 Peregrine Pharmaceuticals Inc., All Rights Reserved   Disclaimer | Safe Harbor